Evidence map›Paper›PMID 42807477›Full record

ReviewInternational journal of transgender health2026

A systematic review of functional neurological disorder in transgender people.

Richard C J Bradlow, Sav Zwickl, Patrick Reardon, Ada S Cheung, Richard A Kanaan

Abstract readReview
In one paragraph

Review in International journal of transgender health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Richard C J BradlowDepartment of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Australia.ORCID https://orcid.org/0009-0005-2111-0932
Sav ZwicklTrans Health Research Group, Department of Medicine, The University of Melbourne, Heidelberg, Australia.ORCID https://orcid.org/0000-0003-2959-5928
Patrick ReardonDepartment of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Australia.
Ada S CheungTrans Health Research Group, Department of Medicine, The University of Melbourne, Heidelberg, Australia.ORCID https://orcid.org/0000-0001-5257-5525
Richard A KanaanDepartment of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Australia.ORCID https://orcid.org/0000-0003-0992-1917

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Trans and gender diverse people may be more likely to have a functional neurological disorder (FND), although the reasons for this are unclear. This systematic review examines the relationship between trans people and FND, to determine if one population is overrepresented in the other, and if gender affirming-care affects symptoms of FND. Methods: A systematic review was conducted as per PRISMA guidelines. Searches were performed on OVID (MEDLINE), PsycINFO, and Web of Science. Studies included focused on both FND and trans people, had subjects of any age, and were original research articles. When the study referred to somatic symptom and related disorders it was included. Study quality was assessed using JBI's critical appraisal tools. Results: Fourteen studies were included. Seven examined the prevalence of FND (or likely FND) in trans people, or of trans people in people in FND or (likely FND patient populations), and seven were case studies or series of trans people with probable FND (total cases = 20). Trans people made up 3-45% of people with FND; somatic symptom and related disorders were present in 6-9.7% of trans people (compared to 5-7% in the general population). Fifteen of the 20 cases were trans people assigned female at birth. Ten of the 20 cases developed FND prior to their social gender affirmation, and seven of those ten's symptoms resolved with gender affirmation. Discussion: Trans people were more likely to develop FND, and somatic symptom and related disorders were slightly overrepresented in trans people. Gender affirmation can lead to resolution of FND symptoms. Trans people appear to make up a considerable proportion of people with FND. FND treatment services need to consider how they provide trans affirming services.

Indexed as

Functional neurological disordersGender affirming hormone therapy (GAHT)Gender minority stressSomatic symptom disordertransgender persons

Identifiers

PMID42807477
PMCPMC13618163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.